XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated other comprehensive (loss) income
Accumulated other comprehensive (loss) income, Foreign currency translation
Accumulated other comprehensive (loss) income, Defined benefit pension plans
Treasury stock
Balance at the beginning of the year at Dec. 31, 2022   $ 2,700 $ 1,094,236 $ 8,857,485   $ (368,124) $ (206,821) $ (1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   8            
Issuance of common stock under employee stock plans     18,098         13,731
Share-based compensation expense     35,773          
Net income $ 970,324     970,324        
Cash dividends paid       (172,693)        
Other       (2)        
Translation adjustments           568    
Change in long-term intercompany notes           (1,091)    
Net investment hedge instruments (loss) gain , net of tax of $9,595 and $(7,126) for the quarter ended September 30, 2024 and 2023, and $4,678 and $(1,004) for the nine months ended September 30, 2024 and 2023, respectively           3,083    
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended September 30, 2024 and 2023 and $(1,095) and $(1,554) for the nine months ended September 30, 2024 and 2023 , respectively             4,776  
Purchase of treasury stock               (6,578)
Balance at the end of the year at Sep. 30, 2023 8,342,509 2,708 1,148,107 9,655,114 $ (567,609) (365,564) (202,045) (1,895,811)
Balance at the beginning of the year at Jun. 30, 2023   2,707 1,123,920 9,372,368   (318,359) (203,637) (1,895,628)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     11,274         (129)
Share-based compensation expense     12,913          
Net income 340,370     340,370        
Cash dividends paid       (57,622)        
Other       (2)        
Translation adjustments           (62,092)    
Change in long-term intercompany notes           (6,994)    
Net investment hedge instruments (loss) gain , net of tax of $9,595 and $(7,126) for the quarter ended September 30, 2024 and 2023, and $4,678 and $(1,004) for the nine months ended September 30, 2024 and 2023, respectively           21,881    
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended September 30, 2024 and 2023 and $(1,095) and $(1,554) for the nine months ended September 30, 2024 and 2023 , respectively             1,592  
Purchase of treasury stock               (54)
Balance at the end of the year at Sep. 30, 2023 8,342,509 2,708 1,148,107 9,655,114 (567,609) (365,564) (202,045) (1,895,811)
Balance at the beginning of the year at Dec. 31, 2023 8,730,191 2,709 1,168,694 9,940,343   (298,835) (186,107) (1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   8            
Issuance of common stock under employee stock plans     25,069         5,843
Share-based compensation expense     34,907          
Net income 988,867     988,867        
Cash dividends paid       (194,068)        
Other       (2)        
Translation adjustments           40,231    
Change in long-term intercompany notes           (1,942)    
Net investment hedge instruments (loss) gain , net of tax of $9,595 and $(7,126) for the quarter ended September 30, 2024 and 2023, and $4,678 and $(1,004) for the nine months ended September 30, 2024 and 2023, respectively           (14,366)    
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended September 30, 2024 and 2023 and $(1,095) and $(1,554) for the nine months ended September 30, 2024 and 2023 , respectively             3,480  
Purchase of treasury stock               (67,995)
Balance at the end of the year at Sep. 30, 2024 9,550,223 2,717 1,228,670 10,735,140 (457,539) (274,912) (182,627) (1,958,765)
Balance at the beginning of the year at Jun. 30, 2024   2,716 1,210,414 10,459,556   (338,606) (183,787) (1,897,889)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     5,513         (476)
Share-based compensation expense     12,743          
Net income 340,241     340,241        
Cash dividends paid       (64,657)        
Other       0        
Translation adjustments           91,052    
Change in long-term intercompany notes           2,106    
Net investment hedge instruments (loss) gain , net of tax of $9,595 and $(7,126) for the quarter ended September 30, 2024 and 2023, and $4,678 and $(1,004) for the nine months ended September 30, 2024 and 2023, respectively           (29,464)    
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended September 30, 2024 and 2023 and $(1,095) and $(1,554) for the nine months ended September 30, 2024 and 2023 , respectively             1,160  
Purchase of treasury stock               (60,400)
Balance at the end of the year at Sep. 30, 2024 $ 9,550,223 $ 2,717 $ 1,228,670 $ 10,735,140 $ (457,539) $ (274,912) $ (182,627) $ (1,958,765)